COIN vs EDIT · P/E 64, rev $7.18B vs rev $32.3M
Coinbase Global Inc (COIN) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the COIN and EDIT stock pages for the full models.
Not investment advice.